Results of the logistic regression model employed to assess the factors associated with HTN control are summarized in Table 3. The type of facility was not significantly associated with HTN control. Co-morbidity and the type of antihypertensive medication used were associated with HTN control. Patients with co-morbidity were more likely than those without co-morbidity to have uncontrolled HTN (adjusted OR = 10.3; 95% CI: 3.8–28.3) while patients on multiple medications were more likely than those on a single medication to have uncontrolled HTN (adjusted OR = 4.6; 95% CI: 1.3–16.1).Table 3Bivariate and multivariate analysis of factors associated with uncontrolled HTNVariablesCrude OR[95%CI] p-valueAdjusted OR [95%CI]a p-valueGender (male vs female)1.3 [0.7–2.4]0.3531.3 [0.6–2.8]0.430Attended school No0.8 [0.4–1.6]0.5301.7 [0.5–5.2]0.365 Yes1Co-morbidity Yes8.5 [3.3–22.1]0.000b 10.3 [3.8–28.3]0.000b No11Type of anti-hypertensive drugs Multitherapy4.9 [1.4–16.6]0.011b 4.6 [1.3–16.1]0.017b No treatment0.8 [0.4–1.6]0.4460.6 [0.3–1.3]0.199 Monotherapy11Experience of side effects Yes1.0 [0.4–2.5]0.9651.1 [0.4–3.1]0.786 No1Treatment adherence No0.9 [0.4–1.6]0.6580.9 [0.4–1.7]0.658 Yes1Time given by HCP Insufficient1.1 [0.4–2.9]0.8270.6 [0.2–2.0]0.390 Sufficient1Type of HCF HC1.1 [0.6–1.9]0.7680.6 [0.3–1.2]0.160 GRH11 CI confidence interval, GRH general referral hospital, HC health center, HCP health care provider, HCF health care facility, OR odds ratio aAdjusted for gender, having attended school, the time given/allocated by the provider, the experience of side effects, types of anti-hypertensive, treatment adherence and co-morbidity; b statistically significant